Skin Barrier Dysfunction: Why the Skin Barrier Breaks Down in Eczema and Chronic Skin Disease
The skin is often thought of as a passive covering that protects the body. In reality, it is a highly active biological barrier that regulates immune activity, protects against microbes, and prevents excessive water loss. When this barrier becomes damaged, the skin becomes vulnerable to inflammation, infection, and chronic disease.
Research over the past two decades has shown that many chronic inflammatory skin conditions, particularly eczema (atopic dermatitis), are closely tied to dysfunction of the skin barrier itself. Rather than being only an immune disorder, chronic skin disease is increasingly understood as a condition where barrier disruption, immune activation, and microbial imbalance interact in a cyclical pattern.
Understanding how the skin barrier works and causes of skin barrier dysfunction helps explain why chronic skin diseases persist and why restoring barrier function is a key component of treatment.
What the Skin Barrier Is and How Skin Barrier Dysfunction Begins
The outermost layer of the skin, known as the stratum corneum, forms the primary physical barrier between the body and the environment. This layer is often described as a “brick and mortar” structure.
The “bricks” are flattened skin cells called corneocytes
The “mortar” is made of lipids such as ceramides, cholesterol, and fatty acids
Together, these structures create a tight seal that performs several essential functions:
Prevents excessive water loss
Blocks entry of irritants and allergens
Protects against pathogens
Helps regulate immune signaling in the skin
This barrier also interacts closely with the skin microbiome, the community of microorganisms that live on the skin and help maintain immune balance.
When functioning properly, the skin barrier maintains hydration, supports beneficial microbes, and prevents immune overactivation.
The Central Role of Filaggrin
One of the most important structural proteins involved in barrier formation is filaggrin.
Filaggrin helps organize keratin fibers inside skin cells and contributes to the formation of natural moisturizing factors (NMF’s) that maintain hydration and acidity of the skin surface. These properties are essential for keeping the barrier intact.
Loss-of-function mutations in the filaggrin (FLG) gene are considered the strongest known genetic risk factor for atopic dermatitis. Individuals with these mutations often have reduced skin hydration and increased permeability to irritants and allergens.
However, recent research shows that filaggrin deficiency is only part of the story. Other genes involved in epidermal differentiation and lipid production also contribute to barrier integrity. The skin barrier should therefore be viewed as a complex system involving genetics, immune signaling, microbial balance, and environmental exposures.
How Inflammation Worsens Skin Barrier Dysfunction
In chronic inflammatory skin disease, immune signaling further weakens the skin barrier.
Atopic dermatitis is driven largely by type-2 immune responses, involving cytokines such as IL-4 and IL-13. These inflammatory signals can directly suppress the expression of genes responsible for producing key barrier proteins and lipids.
As a result, inflammation itself worsens barrier dysfunction. Reduced lipid production and altered epidermal differentiation make the skin more permeable and fragile.
This creates a feedback loop: Barrier damage → allergen and irritant penetration → immune activation → more barrier damage.
Another important factor is the itch–scratch cycle. Inflammatory signaling increases itch sensitivity, leading to scratching that physically disrupts the skin barrier and perpetuates inflammation.
The Skin Microbiome and Barrier Breakdown
The skin barrier is closely linked to the skin microbiome.
Healthy skin hosts a diverse ecosystem of bacteria, viruses, and fungi that help regulate immune responses and prevent colonization by pathogens. In chronic skin disease, this microbial balance becomes disrupted—a process known as dysbiosis.
In atopic dermatitis, the skin often shows:
Reduced microbial diversity
Overgrowth of Staphylococcus aureus
Increased microbial toxins that damage skin cells
This microbial imbalance can worsen inflammation and directly injure the barrier.
Research suggests that early microbial shifts may even contribute to the development of eczema in infancy. Alterations in skin microbial composition during early life can predispose infants to atopic dermatitis and other allergic diseases.
Because of this, the skin microbiome is now considered an integral part of the barrier system rather than a separate factor. Read more here about the gut-skin axis.
What Causes Skin Barrier Dysfunction
Although genetics influence barrier strength, environmental factors also play a major role in barrier breakdown.
Common contributors include:
Harsh detergents and skincare products
Low humidity or dry climates
Allergens and irritants
Microbial infections
Repeated mechanical irritation (scratching)
When these factors interact with underlying genetic susceptibility, the skin barrier may fail to maintain its protective structure.
This helps explain why chronic skin diseases often appear after environmental triggers, even in individuals without known genetic mutations.
Genetics can be an easy scapegoat, but given what we know about epigenetics these days, there are ways to change the genetic expression of the mutated genes and start feeling and looking our best.
A New Perspective on Chronic Skin Disease
Modern research increasingly views chronic inflammatory skin conditions as barrier-driven diseases. Read more about triggers of chronic eczema here.
The skin barrier is not simply damaged as a consequence of inflammation; it is often one of the initiating factors that allows inflammation to develop in the first place.
Barrier dysfunction allows allergens, microbes, and irritants to penetrate the skin more easily, which activates immune pathways and perpetuates disease.
Because of this, therapies that support barrier repair, along with controlling immune activation, have become a central focus in the management of chronic skin disorders.
Understanding the skin barrier as a dynamic system involving genetics, immunity, and the microbiome provides a more complete picture of why chronic skin diseases develop and why they can be so persistent.
Research Articles (PubMed)
Filaggrin and beyond: New insights into the skin barrier in atopic dermatitis and allergic diseases (2024)https://pubmed.ncbi.nlm.nih.gov/37758055/
The skin barrier and microbiome in infantile atopic dermatitis development: can skincare prevent onset? (2024)https://pubmed.ncbi.nlm.nih.gov/38887075/
